nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2A6—prostate cancer	0.187	0.414	CbGaD
Dexfenfluramine—CYP2E1—prostate cancer	0.133	0.294	CbGaD
Dexfenfluramine—CYP2C19—prostate cancer	0.132	0.291	CbGaD
Dexfenfluramine—CYP2C19—Nilutamide—prostate cancer	0.0356	0.0841	CbGbCtD
Dexfenfluramine—CYP2C19—Bicalutamide—prostate cancer	0.0356	0.0841	CbGbCtD
Dexfenfluramine—CYP2E1—Estrone—prostate cancer	0.034	0.0804	CbGbCtD
Dexfenfluramine—CYP2C9—Bicalutamide—prostate cancer	0.0296	0.0699	CbGbCtD
Dexfenfluramine—CYP2C9—Nilutamide—prostate cancer	0.0296	0.0699	CbGbCtD
Dexfenfluramine—CYP2C19—Flutamide—prostate cancer	0.0295	0.0697	CbGbCtD
Dexfenfluramine—CYP1A2—Flutamide—prostate cancer	0.0272	0.0643	CbGbCtD
Dexfenfluramine—CYP2D6—Bicalutamide—prostate cancer	0.0271	0.0639	CbGbCtD
Dexfenfluramine—CYP2D6—Abiraterone—prostate cancer	0.0224	0.053	CbGbCtD
Dexfenfluramine—CYP2E1—Mitoxantrone—prostate cancer	0.0202	0.0478	CbGbCtD
Dexfenfluramine—CYP1A2—Estrone—prostate cancer	0.0197	0.0465	CbGbCtD
Dexfenfluramine—CYP2C9—Estrone—prostate cancer	0.0177	0.0419	CbGbCtD
Dexfenfluramine—CYP2C9—Capecitabine—prostate cancer	0.0134	0.0317	CbGbCtD
Dexfenfluramine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0129	0.0304	CbGbCtD
Dexfenfluramine—CYP2E1—Etoposide—prostate cancer	0.0128	0.0301	CbGbCtD
Dexfenfluramine—CYP2C19—Estradiol—prostate cancer	0.0122	0.0289	CbGbCtD
Dexfenfluramine—CYP1A2—Estradiol—prostate cancer	0.0113	0.0267	CbGbCtD
Dexfenfluramine—CYP2C19—Prednisone—prostate cancer	0.0105	0.0249	CbGbCtD
Dexfenfluramine—CYP2C9—Estradiol—prostate cancer	0.0102	0.0241	CbGbCtD
Dexfenfluramine—CYP1A2—Etoposide—prostate cancer	0.00738	0.0174	CbGbCtD
Dexfenfluramine—CYP2D6—Doxorubicin—prostate cancer	0.00415	0.0098	CbGbCtD
Dexfenfluramine—CYP2C19—urine—prostate cancer	0.0018	0.155	CbGeAlD
Dexfenfluramine—CYP1A2—urine—prostate cancer	0.00147	0.126	CbGeAlD
Dexfenfluramine—CYP2C9—urine—prostate cancer	0.00139	0.12	CbGeAlD
Dexfenfluramine—CYP2E1—urine—prostate cancer	0.00132	0.114	CbGeAlD
Dexfenfluramine—CYP2D6—urine—prostate cancer	0.00105	0.0899	CbGeAlD
Dexfenfluramine—CYP2A6—prostate gland—prostate cancer	0.001	0.0863	CbGeAlD
Dexfenfluramine—CYP2A6—seminal vesicle—prostate cancer	0.000849	0.073	CbGeAlD
Dexfenfluramine—CYP2E1—prostate gland—prostate cancer	0.000475	0.0408	CbGeAlD
Dexfenfluramine—CYP2E1—seminal vesicle—prostate cancer	0.000401	0.0345	CbGeAlD
Dexfenfluramine—Methamphetamine—SLC22A3—prostate cancer	0.000368	0.625	CrCbGaD
Dexfenfluramine—CYP1A2—renal system—prostate cancer	0.00036	0.0309	CbGeAlD
Dexfenfluramine—CYP2E1—renal system—prostate cancer	0.000323	0.0278	CbGeAlD
Dexfenfluramine—CYP2E1—urethra—prostate cancer	0.000318	0.0273	CbGeAlD
Dexfenfluramine—CYP2D6—renal system—prostate cancer	0.000256	0.022	CbGeAlD
Dexfenfluramine—HTR2B—lymph node—prostate cancer	0.000247	0.0212	CbGeAlD
Dexfenfluramine—Cinacalcet—CYP3A4—prostate cancer	0.000221	0.375	CrCbGaD
Dexfenfluramine—CYP2E1—testis—prostate cancer	0.000209	0.018	CbGeAlD
Dexfenfluramine—CYP2D6—testis—prostate cancer	0.000166	0.0142	CbGeAlD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CG—prostate cancer	3.73e-06	3.31e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CAV1—prostate cancer	3.73e-06	3.31e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAP2K1—prostate cancer	3.73e-06	3.31e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.72e-06	3.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GGT1—prostate cancer	3.71e-06	3.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.71e-06	3.29e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CD—prostate cancer	3.71e-06	3.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.69e-06	3.27e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KDR—prostate cancer	3.69e-06	3.27e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.69e-06	3.27e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NQO1—prostate cancer	3.68e-06	3.26e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CA—prostate cancer	3.67e-06	3.25e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SERPINE1—prostate cancer	3.67e-06	3.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NCOA1—prostate cancer	3.66e-06	3.24e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NQO1—prostate cancer	3.65e-06	3.23e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—KRAS—prostate cancer	3.63e-06	3.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TH—prostate cancer	3.63e-06	3.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.61e-06	3.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.61e-06	3.2e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ESR1—prostate cancer	3.6e-06	3.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TH—prostate cancer	3.6e-06	3.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.59e-06	3.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PRKACB—prostate cancer	3.59e-06	3.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.57e-06	3.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.56e-06	3.15e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.55e-06	3.15e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGF2—prostate cancer	3.55e-06	3.15e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.54e-06	3.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—INS—prostate cancer	3.53e-06	3.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.53e-06	3.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—prostate cancer	3.51e-06	3.11e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BAD—prostate cancer	3.51e-06	3.11e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.5e-06	3.1e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOS3—prostate cancer	3.5e-06	3.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.5e-06	3.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—RXRA—prostate cancer	3.48e-06	3.09e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CREBBP—prostate cancer	3.46e-06	3.07e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARA—prostate cancer	3.45e-06	3.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GGT1—prostate cancer	3.42e-06	3.03e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—JAK2—prostate cancer	3.4e-06	3.02e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APC—prostate cancer	3.4e-06	3.02e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CG—prostate cancer	3.4e-06	3.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GGT1—prostate cancer	3.39e-06	3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.38e-06	3e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NCOA2—prostate cancer	3.38e-06	3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NCOA1—prostate cancer	3.37e-06	2.98e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IRS1—prostate cancer	3.36e-06	2.98e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGF—prostate cancer	3.36e-06	2.98e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—COMT—prostate cancer	3.35e-06	2.97e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTP1—prostate cancer	3.34e-06	2.96e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NCOA1—prostate cancer	3.34e-06	2.96e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CA—prostate cancer	3.33e-06	2.96e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MDM2—prostate cancer	3.32e-06	2.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.32e-06	2.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.29e-06	2.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ITPR1—prostate cancer	3.28e-06	2.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CD—prostate cancer	3.28e-06	2.91e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ERBB2—prostate cancer	3.27e-06	2.9e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GSK3B—prostate cancer	3.26e-06	2.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CAV1—prostate cancer	3.24e-06	2.87e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CB—prostate cancer	3.23e-06	2.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.23e-06	2.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.23e-06	2.86e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—INS—prostate cancer	3.22e-06	2.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—RXRA—prostate cancer	3.2e-06	2.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—RXRA—prostate cancer	3.17e-06	2.81e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CREBBP—prostate cancer	3.15e-06	2.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.15e-06	2.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NQO1—prostate cancer	3.12e-06	2.76e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF1—prostate cancer	3.11e-06	2.76e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL8—prostate cancer	3.1e-06	2.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TYMS—prostate cancer	3.1e-06	2.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NOS3—prostate cancer	3.1e-06	2.75e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—prostate cancer	3.1e-06	2.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.09e-06	2.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—COMT—prostate cancer	3.08e-06	2.73e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TH—prostate cancer	3.07e-06	2.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTP1—prostate cancer	3.07e-06	2.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—prostate cancer	3.07e-06	2.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—COMT—prostate cancer	3.06e-06	2.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.05e-06	2.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTP1—prostate cancer	3.04e-06	2.7e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.04e-06	2.7e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1B—prostate cancer	3.03e-06	2.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.02e-06	2.68e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ITPR1—prostate cancer	3.02e-06	2.68e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAP2K1—prostate cancer	3.01e-06	2.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—LPL—prostate cancer	3.01e-06	2.67e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—prostate cancer	3e-06	2.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ITPR1—prostate cancer	2.99e-06	2.65e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CD—prostate cancer	2.99e-06	2.65e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.99e-06	2.65e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CASP3—prostate cancer	2.97e-06	2.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—prostate cancer	2.97e-06	2.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CA—prostate cancer	2.96e-06	2.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SERPINE1—prostate cancer	2.96e-06	2.62e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—prostate cancer	2.95e-06	2.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CG—prostate cancer	2.95e-06	2.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.94e-06	2.61e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—KRAS—prostate cancer	2.93e-06	2.6e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.91e-06	2.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GGT1—prostate cancer	2.89e-06	2.57e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCND1—prostate cancer	2.89e-06	2.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.88e-06	2.56e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CTNNB1—prostate cancer	2.86e-06	2.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGF2—prostate cancer	2.86e-06	2.54e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CB—prostate cancer	2.86e-06	2.54e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TYMS—prostate cancer	2.85e-06	2.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.85e-06	2.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTGS2—prostate cancer	2.84e-06	2.51e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TYMS—prostate cancer	2.83e-06	2.51e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOS3—prostate cancer	2.82e-06	2.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.82e-06	2.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.81e-06	2.49e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—prostate cancer	2.81e-06	2.49e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1A—prostate cancer	2.8e-06	2.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—prostate cancer	2.8e-06	2.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—INS—prostate cancer	2.79e-06	2.48e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTEN—prostate cancer	2.79e-06	2.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—LPL—prostate cancer	2.77e-06	2.45e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—LPL—prostate cancer	2.74e-06	2.43e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JAK2—prostate cancer	2.74e-06	2.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CREBBP—prostate cancer	2.74e-06	2.43e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—prostate cancer	2.72e-06	2.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—RXRA—prostate cancer	2.71e-06	2.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—prostate cancer	2.71e-06	2.4e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CA—prostate cancer	2.69e-06	2.38e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MDM2—prostate cancer	2.68e-06	2.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.67e-06	2.37e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EP300—prostate cancer	2.66e-06	2.36e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARA—prostate cancer	2.66e-06	2.36e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.65e-06	2.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.65e-06	2.35e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ERBB2—prostate cancer	2.64e-06	2.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.64e-06	2.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ERCC2—prostate cancer	2.63e-06	2.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—COMT—prostate cancer	2.61e-06	2.32e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CB—prostate cancer	2.61e-06	2.31e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.6e-06	2.31e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CD—prostate cancer	2.59e-06	2.3e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SRC—prostate cancer	2.59e-06	2.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ITPR1—prostate cancer	2.56e-06	2.27e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—prostate cancer	2.52e-06	2.24e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.52e-06	2.23e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL8—prostate cancer	2.5e-06	2.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CAV1—prostate cancer	2.5e-06	2.22e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—prostate cancer	2.5e-06	2.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.49e-06	2.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTEN—prostate cancer	2.47e-06	2.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—prostate cancer	2.47e-06	2.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NOS3—prostate cancer	2.45e-06	2.17e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1B—prostate cancer	2.45e-06	2.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARA—prostate cancer	2.45e-06	2.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARA—prostate cancer	2.42e-06	2.15e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—prostate cancer	2.42e-06	2.15e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TYMS—prostate cancer	2.42e-06	2.14e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CASP3—prostate cancer	2.4e-06	2.13e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—prostate cancer	2.39e-06	2.12e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—prostate cancer	2.39e-06	2.12e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.39e-06	2.12e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—prostate cancer	2.38e-06	2.11e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—EP300—prostate cancer	2.36e-06	2.09e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LPL—prostate cancer	2.35e-06	2.08e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCND1—prostate cancer	2.33e-06	2.07e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—prostate cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—prostate cancer	2.31e-06	2.05e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CTNNB1—prostate cancer	2.31e-06	2.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CAV1—prostate cancer	2.3e-06	2.04e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CAV1—prostate cancer	2.28e-06	2.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.28e-06	2.02e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—prostate cancer	2.27e-06	2.01e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—prostate cancer	2.27e-06	2.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.26e-06	2.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.26e-06	2e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	2.26e-06	2e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTEN—prostate cancer	2.25e-06	2e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ERCC2—prostate cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS2—prostate cancer	2.24e-06	1.99e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—prostate cancer	2.2e-06	1.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.18e-06	1.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—INS—prostate cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EP300—prostate cancer	2.15e-06	1.9e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KRAS—prostate cancer	2.14e-06	1.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.11e-06	1.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.11e-06	1.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SRC—prostate cancer	2.09e-06	1.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.08e-06	1.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARA—prostate cancer	2.07e-06	1.84e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—prostate cancer	2.03e-06	1.8e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—prostate cancer	2.01e-06	1.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—INS—prostate cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.97e-06	1.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—INS—prostate cancer	1.97e-06	1.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTEN—prostate cancer	1.95e-06	1.73e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CAV1—prostate cancer	1.95e-06	1.73e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.94e-06	1.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—prostate cancer	1.91e-06	1.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NOS3—prostate cancer	1.89e-06	1.68e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.87e-06	1.66e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.87e-06	1.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—EP300—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.82e-06	1.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.77e-06	1.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.74e-06	1.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CA—prostate cancer	1.74e-06	1.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—prostate cancer	1.74e-06	1.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NOS3—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NOS3—prostate cancer	1.72e-06	1.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—INS—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.61e-06	1.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.6e-06	1.42e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.58e-06	1.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—prostate cancer	1.54e-06	1.36e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTEN—prostate cancer	1.51e-06	1.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NOS3—prostate cancer	1.47e-06	1.31e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—EP300—prostate cancer	1.44e-06	1.27e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—prostate cancer	1.42e-06	1.26e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—prostate cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTEN—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.38e-06	1.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTEN—prostate cancer	1.37e-06	1.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.35e-06	1.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—EP300—prostate cancer	1.32e-06	1.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—EP300—prostate cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTEN—prostate cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—prostate cancer	1.13e-06	9.98e-06	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—EP300—prostate cancer	1.12e-06	9.93e-06	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.06e-06	9.43e-06	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.78e-07	8.67e-06	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.7e-07	8.6e-06	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—prostate cancer	8.69e-07	7.7e-06	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.29e-07	7.35e-06	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—prostate cancer	7.99e-07	7.08e-06	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—prostate cancer	7.92e-07	7.02e-06	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—prostate cancer	6.77e-07	6e-06	CbGpPWpGaD
